Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma

PURPOSE: Esophageal squamous cell cancer (ESCC) is a deadly malignant tumor characterized by an overall 5-year survival rate below 20%, with China accounting for approximately 50% of all cases worldwide. Our previous studies have demonstrated that high integrin-linked kinase (ILK) expression plays a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Juan, Ma, Xiaoli, Cao, Leiyu, Wei, Yu, Gao, Yan, Qu, Chengcheng, Maimaitiming, Nuersimanguli, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815933/
https://www.ncbi.nlm.nih.gov/pubmed/36618074
http://dx.doi.org/10.1155/2022/3658334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815933/
https://www.ncbi.nlm.nih.gov/pubmed/36618074
http://dx.doi.org/10.1155/2022/3658334

Ejemplares similares